JIANGXI BIO
06915Listed醫療健康 · 江西生物制品研究所股份有限公司是一家主要从事生物制品研发、生产和销售的中国公司。
Neutral
71.5
/100
- Offer price
- HK$11.20
- Final offer price
- HK$11.20
- Lot / entry fee
- 500 shares · HK$6K
- Proceeds
- HK$405.8M
- Sponsor
- CICC / China Merchants Securities
- Est. margin oversub.
- 219.7x
- Public oversub.
- 476.6x
- One-lot win rate
- 2.0%
- First-day return
- -12.7%
Offer starts
Jun 22
Offer closes
Jun 25
Grey market
Jun 29
Listing
Jun 30
AI reference scoring and scenarios
After grey market
After grey market L1 heat score
71.5/ 100
Data coverage High
Target
Historical calibration
Listing-day trend
Neutral-positivePartial basis
Up probability
79.2%
First-day reference range
-30.8% – +8.3%
Published outcome check
First-day resultDown-12.7%Normal
Our call: Direction off
Covered 17/25 core factors
UsedMissingNot yet scorableN/A
Margin oversubscription
High heatOffer size
Good qualityCornerstone lockup
—Post-lockup offer value
—Recent same-rule trend
Strong trendRecent same-type trend
Strong trendRecent sector trend
Strong trendValuation
Average appealFundamental quality
Good qualityGrowth quality
Weak qualityProfitability
Weaker qualityCash runway
—Customer concentration
—Cornerstone quality
—Sponsor record
Strong recordGreenshoe arrangementGreenshoe: yes · 15%
Average supportStabilizer track recordCICC
Strong recordA-share pre-grey trend
—A-share listing-day trend
—Public oversubscription
High heatOne-lot win rate
High heatInternational placing
High heatFinal pricing position
—Actual greenshoe useCumulative use +100.0%
Low supportGrey market return
Poor trendThe assessment and probability ranges are informational only and are not investment advice.
AI Research Report
After grey marketThe analysis report for this IPO is being generated.